For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
A dry-powder inhaler (DPI) is a device that delivers medication to the lungs in the form of a dry powder.
Scope of the Report:
Globally, increasing number of people with respiratory diseases and diabetes mellitus are expected to remain the growth drivers for dry powder inhaler devices during the period of study.
The worldwide market for Dry Powder Inhaler Devices is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
This report focuses on the Dry Powder Inhaler Devices in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
- Bayer HealthCare
- Sandoz International
- Teva Pharmaceutical Industries
- AKELA Pharma
- Hovione FarmaCiencia
- OPKO Health
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Capsule Based
- Blister Based
- Reservoir/Cartridge Based
Market Segment by Applications, can be divided into
- Hospitals and Clinics
There are 15 Chapters to deeply display the global Dry Powder Inhaler Devices market.
Chapter 1, to describe Dry Powder Inhaler Devices Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Dry Powder Inhaler Devices, with sales, revenue, and price of Dry Powder Inhaler Devices, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Dry Powder Inhaler Devices, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Dry Powder Inhaler Devices market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Dry Powder Inhaler Devices sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source